• 1. Emerging investigator series: kinetics of diopside reactivity for carbon mineralization in mafic–ultramafic rocks
  BrianaAguila,LandonHardee,H.ToddSchaef,SiavashZare,MohammadJavadAbdolhosseiniQomi,JarrodV.Crum,JadeE.HollimanJr.,ElenaTajueloRodriguez,LawrenceM.Anovitz,KevinM.Rosso,QuinR.S.Miller
• 2. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 3. Excimer formation effects and trap-assisted charge recombination loss channels in organic solar cells of perylene diimide dimer acceptors?
  Min Kim,Jae-Joon Lee,Tengling Ye,Panagiotis E. Keivanidis,Kilwon Cho J. Mater. Chem. C, 2020,8, 1686-1696
• 4. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 5. Fe3O4 nanoclusters highly dispersed on a porous graphene support as an additive for improving the hydrogen storage properties of LiBH4?
  Guang Xu,Wei Zhang,Ying Zhang,Xiaoxia Zhao,Ping Wen,Di Ma RSC Adv., 2018,8, 19353-19361

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Amino acids and derivatives

Introduction to Ethyl (2S)-Piperidine-2-Carboxylate (CAS No. 22328-78-5)

Ethyl (2S)-piperidine-2-carboxylate, a compound with the chemical identifier CAS No. 22328-78-5, is a significant molecule in the field of pharmaceutical chemistry and drug development. This compound belongs to the piperidine class, which is well-known for its diverse biological activities and applications in medicinal chemistry. The stereochemical configuration at the carbon-2 position, specifically the (S) configuration, plays a crucial role in determining its pharmacological properties and interactions with biological targets.

The synthesis and characterization of ethyl (2S)-piperidine-2-carboxylate have been extensively studied due to its potential as a building block in the design of novel therapeutic agents. Recent advancements in synthetic methodologies have enabled more efficient and scalable production of this compound, making it more accessible for research and development purposes. The use of chiral resolution techniques has been particularly important in ensuring the purity and enantiomeric excess of the (S)-isomer, which is often required for optimal biological activity.

One of the most compelling aspects of ethyl (2S)-piperidine-2-carboxylate is its role as a precursor in the synthesis of more complex molecules. For instance, it has been utilized in the development of protease inhibitors, which are critical in the treatment of various diseases, including HIV and cancer. The piperidine ring provides a suitable scaffold for binding to specific enzymatic targets, while the carboxylate ester group offers opportunities for further functionalization. This flexibility makes ethyl (2S)-piperidine-2-carboxylate a valuable tool for medicinal chemists.

Recent research has also highlighted the importance of ethyl (2S)-piperidine-2-carboxylate in the development of central nervous system (CNS) drugs. Piperidine derivatives are known to interact with various neurotransmitter systems, making them potential candidates for treating neurological disorders such as depression, anxiety, and epilepsy. The (S)-configuration of ethyl (2S)-piperidine-2-carboxylate has been shown to enhance its affinity for certain receptors, leading to improved therapeutic efficacy. This finding underscores the significance of stereochemistry in drug design and development.

The pharmacokinetic properties of ethyl (2S)-piperidine-2-carboxylate have also been thoroughly investigated. Studies have demonstrated that this compound exhibits good oral bioavailability and moderate metabolic stability, which are essential characteristics for a successful drug candidate. Additionally, its solubility profile has been optimized through structural modifications, improving its pharmacokinetic behavior. These attributes make ethyl (2S)-piperidine-2-carboxylate an attractive candidate for further clinical development.

In conclusion, ethyl (2S)-piperidine-2-carboxylate is a versatile and important compound in pharmaceutical chemistry. Its synthesis, stereochemistry, and biological activity have been extensively studied, providing valuable insights into its potential as a therapeutic agent. The ongoing research in this area continues to uncover new applications and opportunities for this compound, making it a cornerstone in the development of innovative drugs.

• 77034-33-4(Ethyl Piperidine-2-carboxylate hydrochloride)
• 15862-72-3(ethyl piperidine-2-carboxylate)
• 874360-22-2(2-Piperidinecarboxylic acid, octacosyl ester)
• 123495-48-7(ethyl (2S)-piperidine-2-carboxylate;hydrochloride)
• 651330-77-7(2-Piperidinecarboxylic acid, 3-aminopropyl ester)
• 103954-36-5(Nε-(Ethoxycarbonylethyl)-L-lysine Methyl Ester (Mixture of Diastereomers))
• 22328-77-4((R)-Ethyl piperidine-2-carboxylate)
• 82834-12-6(N-(S)-1-Carbethoxybutyl-(S)-alanine)
• 183786-20-1((R)-Ethyl piperidine-2-carboxylate hydrochloride)
• 475204-12-7(2-Piperidinecarboxylic acid ethyl ester)